Actively Recruiting
Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)
Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-10-10
60
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether acupuncture is a practical treatment option for cancer survivors who experience joint pain. The study focuses on diverse underserved cancer survivors with chronic musculoskeletal pain, aiming to understand how feasible it is to enroll and treat patients with acupuncture in this population. The trial is sponsored by the Memorial Sloan Kettering Cancer Center and does not involve randomization or blinding. Participants are assigned to one of two groups. One group will receive 10 weekly acupuncture treatments over 10 weeks as a non-drug procedure. The other group will continue with standard medical care, which may include pain medications and other treatments. This non-randomized design allows comparison of acupuncture with usual care. During the study, participants will complete questionnaires and other study activities to report their pain and treatment experience. Researchers will monitor enrollment rates over the first year to measure study feasibility. The total duration of treatment involvement for acupuncture participants is 10 weeks, with ongoing monitoring of pain levels and other patient-reported outcomes. The study includes adults who speak English or Spanish and have a history of cancer with joint pain.
CONDITIONS
Brief Title
An Acupuncture Study for Cancer Survivors With Joint Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English- or Spanish-speaking adults
- Non-white or Hispanic women with a prior cancer diagnosis
- Stable oncological disease or no evidence of disease per clinical documentation or clinician assessment
- Worst pain rated 4 or higher on a 0-10 scale in the preceding week
- At least 15 days with pain in the past 30 days
- Pain lasting at least 1 month
- Willing and able to complete questionnaires and other study activities
- Willing and able to provide informed consent for the trial
You will not qualify if you...
- Completed active cancer treatment less than 4 weeks prior to study
- Pain attributed to inflammatory arthritis such as rheumatoid arthritis or gout
- Procedures involving affected joints within the last month or planned in the next 14 weeks
- Acupuncture use for pain in the past 3 months
- Implanted electronic device such as a pacemaker
- Other non-musculoskeletal pain syndromes can be present if musculoskeletal pain is primary
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 weeks
Participants receive acupuncture treatments to manage chronic musculoskeletal joint pain.
10 weekly visits (in-person)
Trial Site Locations
Total: 2 locations
1
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, United States, 10065
Actively Recruiting
2
Jamaica Hospital Medical Center
Richmond Hill, New York, United States, 11418
Actively Recruiting
Research Team
K
Kevin Liou, MD
P
Pamela Drullinsky, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here